Inogen Stock Price, News & Analysis (NASDAQ:INGN)

$115.95 -0.20 (-0.17 %)
(As of 01/18/2018 02:40 AM ET)
Previous Close$116.15
Today's Range$115.00 - $117.46
52-Week Range$62.69 - $130.05
Volume136,700 shs
Average Volume181,009 shs
Market Capitalization$2.41 billion
P/E Ratio94.27
Dividend YieldN/A
Beta1.13

About Inogen (NASDAQ:INGN)

Inogen logoInogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Receive INGN News and Ratings via Email

Sign-up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:INGN
CUSIPN/A
Phone805-562-0500

Debt

Debt-to-Equity RatioN/A
Current Ratio6.20%
Quick Ratio5.73%

Price-To-Earnings

Trailing P/E Ratio94.2682926829268
Forward P/E Ratio97.44
P/E Growth3.92

Sales & Book Value

Annual Sales$202.83 million
Price / Sales11.93
Cash Flow$1.69 per share
Price / Cash68.74
Book Value$8.99 per share
Price / Book12.90

Profitability

Trailing EPS$1.23
Net Income$20.51 million
Net Margins11.36%
Return on Equity13.37%
Return on Assets11.16%

Miscellaneous

Employees166
Outstanding Shares20,870,000

Inogen (NASDAQ:INGN) Frequently Asked Questions

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

How were Inogen's earnings last quarter?

Inogen Inc (NASDAQ:INGN) released its quarterly earnings results on Tuesday, November, 7th. The medical technology company reported $0.33 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.29 by $0.04. The medical technology company had revenue of $69 million for the quarter, compared to analyst estimates of $63.55 million. Inogen had a return on equity of 13.37% and a net margin of 11.36%. The firm's revenue was up 26.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.25 earnings per share. View Inogen's Earnings History.

Where is Inogen's stock going? Where will Inogen's stock price be in 2018?

6 Wall Street analysts have issued 12 month price targets for Inogen's shares. Their predictions range from $75.00 to $125.00. On average, they expect Inogen's stock price to reach $98.50 in the next year. View Analyst Ratings for Inogen.

What are Wall Street analysts saying about Inogen stock?

Here are some recent quotes from research analysts about Inogen stock:

  • 1. According to Zacks Investment Research, "Over the last six months, Inogen has outperformed the broader industry in terms of price. The company expects direct-to-consumer sales to be its fastest growing channel, followed by domestic business-to-business sales in the coming quarters, with solid focus in Europe. The company is also upbeat about its full-year 2017 revenue guidance. Solid domestic and international business-to-business sales has been boosting Inogen. The company took a series of strategic initiatives to strengthen its product offerings and market position. On the flip side, declining rental revenues raise concern. Moreover, since the company generates a significant portion of its revenues from the international market, volatile foreign exchange rate will continue to raise concern. Low POC adoption, intensifying competition, reimbursement cuts and foreign exchange headwinds are other major concerns." (1/10/2018)
  • 2. Needham & Company LLC analysts commented, "INGN beat consensus revenue, EBITDA, and EPS in 1Q17. Management maintained its 2017 revenue and EBITDA guidance and raised its 2017 net income guidance. The revenue upside was driven by 49% growth in B2B more than offsetting 0% growth in DTC. We think that the strong 84% growth in domestic B2B provides further evidence that home medical equipment companies (HMEs) are increasingly adopting portable oxygen concentrators." (5/10/2017)
  • 3. Stifel Nicolaus analysts commented, "Inogen (INGN) reported 4Q16 after the close on February 28, 2017 with results better than our expectations. Revenue, Adjusted-EBITDA, and Net Income all exceeded our expectations. Management slightly raised its recently established 2017 guidance. In our view, INGN has a great longer-term story that should continue to evolve and grow as disruption occurs in the high cost delivery model of oxygen to those that need it. Maintain Hold and adjust target to $65 based on a range of valuation multiples." (3/1/2017)

Who are some of Inogen's key competitors?

Who are Inogen's key executives?

Inogen's management team includes the folowing people:

  • Heath Lukatch Ph.D., Independent Chairman of the Board (Age 50)
  • Scott Wilkinson, President, Chief Executive Officer, Director (Age 52)
  • Alison Bauerlein, Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer (Age 35)
  • Byron Myers, Executive Vice President of Sales and Marketing (Age 37)
  • Matthew Scribner, Executive Vice President - Operations (Age 49)
  • Brenton Taylor, Executive Vice President - Engineering (Age 35)
  • Benjamin M. Anderson-Ray, Independent Director (Age 62)
  • Scott A. Beardsley, Independent Director (Age 49)
  • R. Scott Greer, Independent Director (Age 58)
  • Raymond O. Huggenberger, Independent Director (Age 58)

Who owns Inogen stock?

Inogen's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Schwab Charles Investment Management Inc. (0.38%), Bank of Montreal Can (0.08%), Louisiana State Employees Retirement System (0.04%) and Simplex Trading LLC (0.01%). Company insiders that own Inogen stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Heath Lukatch, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger and Scott Wilkinson. View Institutional Ownership Trends for Inogen.

Who sold Inogen stock? Who is selling Inogen stock?

Inogen's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can. Company insiders that have sold Inogen company stock in the last year include Alison Bauerlein, Brenton Taylor, Byron Myers, Heath Lukatch, Matt Scribner, Ray Benjamin M Anderson, Raymond Huggenberger and Scott Wilkinson. View Insider Buying and Selling for Inogen.

Who bought Inogen stock? Who is buying Inogen stock?

Inogen's stock was bought by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Simplex Trading LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Inogen.

How do I buy Inogen stock?

Shares of Inogen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Inogen's stock price today?

One share of Inogen stock can currently be purchased for approximately $115.95.

How big of a company is Inogen?

Inogen has a market capitalization of $2.41 billion and generates $202.83 million in revenue each year. The medical technology company earns $20.51 million in net income (profit) each year or $1.23 on an earnings per share basis. Inogen employs 166 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The medical technology company can be reached via phone at 805-562-0500 or via email at [email protected]


MarketBeat Community Rating for Inogen (INGN)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  200 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  295
MarketBeat's community ratings are surveys of what our community members think about Inogen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Inogen (NASDAQ:INGN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldBuy
Consensus Rating Score: 2.672.672.402.75
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $98.50$98.50$90.80$91.00
Price Target Upside: 16.61% downside16.61% downside13.10% downside3.33% downside

Inogen (NASDAQ:INGN) Consensus Price Target History

Price Target History for Inogen (NASDAQ:INGN)

Inogen (NASDAQ:INGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017Leerink SwannReiterated RatingOutperform$115.00 -> $120.00N/AView Rating Details
11/8/2017Needham & Company LLCBoost Price TargetStrong-Buy$108.00 -> $125.00N/AView Rating Details
9/12/2017Piper Jaffray CompaniesReiterated RatingHold$90.00LowView Rating Details
6/26/2017JPMorgan Chase & Co.Boost Price TargetOverweight$102.00LowView Rating Details
5/10/2017Stifel NicolausBoost Price TargetHold -> Hold$65.00 -> $75.00HighView Rating Details
4/18/2017SidotiInitiated CoverageNeutral -> Neutral$79.00MediumView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Inogen (NASDAQ:INGN) Earnings History and Estimates Chart

Earnings by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ INGN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017Q3 2017$0.29$0.33$63.55 million$69.00 millionViewN/AView Earnings Details
8/3/2017Q2 2017$0.28$0.38$59.99 million$64.10 millionViewListenView Earnings Details
5/9/2017Q1 2017$0.12$0.27$49.06 million$52.50 millionViewListenView Earnings Details
2/28/2017Q416$0.10$0.25$46.19 million$50.85 millionViewListenView Earnings Details
11/3/2016Q316$0.13$0.16$47.89 million$54.42 millionViewN/AView Earnings Details
8/4/2016Q216$0.20$0.25$52.44 million$54.57 millionViewN/AView Earnings Details
5/9/2016Q116$0.12$0.11$41.75 million$43.00 millionViewN/AView Earnings Details
3/14/2016Q415$0.07$0.19$29.10 million$40.40 millionViewN/AView Earnings Details
11/10/2015Q315$0.13$0.13$36.99 million$40.80 millionViewListenView Earnings Details
8/11/2015Q215$0.15$0.17$36.88 million$44.00 millionViewListenView Earnings Details
5/12/2015Q1$0.07$0.08$29.98 million$33.70 millionViewListenView Earnings Details
4/27/2015Q115$0.03$0.06$19.80 million$29.10 millionViewN/AView Earnings Details
11/11/2014Q3 2014$0.06$0.11$28.00 million$29.40 millionViewN/AView Earnings Details
8/12/2014Q214$0.07$0.11$23.93 million$30.40 millionViewN/AView Earnings Details
5/13/2014Q114$0.04$0.05$20.70 million$23.60 millionViewN/AView Earnings Details
3/27/2014Q4 13$0.02$0.89$18.71 million$19.76 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Inogen (NASDAQ:INGN) Earnings Estimates

2018 EPS Consensus Estimate: $1.45
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.22$0.31$0.27
Q2 20182$0.44$0.45$0.45
Q3 20182$0.42$0.44$0.43
Q4 20182$0.30$0.31$0.31
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Inogen (NASDAQ:INGN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Inogen (NASDAQ INGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.31%
Insider Trades by Quarter for Inogen (NASDAQ:INGN)
Institutional Ownership by Quarter for Inogen (NASDAQ:INGN)

Inogen (NASDAQ INGN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/2/2018Ray Benjamin M AndersonDirectorSell1,000$119.06$119,060.001,000View SEC Filing  
12/15/2017Raymond HuggenbergerDirectorSell14,000$119.92$1,678,880.007,808View SEC Filing  
12/14/2017Matt ScribnerEVPSell2,500$120.34$300,850.007,297View SEC Filing  
12/11/2017Byron MyersEVPSell10,000$116.81$1,168,100.0048,600View SEC Filing  
12/1/2017Heath LukatchDirectorSell2,500$126.40$316,000.00View SEC Filing  
11/17/2017Byron MyersEVPSell35,000$116.77$4,086,950.0048,600View SEC Filing  
11/13/2017Matt ScribnerEVPSell2,500$112.35$280,875.00View SEC Filing  
10/16/2017Raymond HuggenbergerDirectorSell14,000$94.07$1,316,980.007,808View SEC Filing  
10/12/2017Matt ScribnerEVPSell2,500$93.88$234,700.00View SEC Filing  
10/10/2017Alison BauerleinEVPSell15,000$94.93$1,423,950.00View SEC Filing  
9/15/2017Raymond HuggenbergerDirectorSell14,000$102.30$1,432,200.007,808View SEC Filing  
9/11/2017Matt ScribnerEVPSell2,500$103.23$258,075.006,964View SEC Filing  
9/6/2017Heath LukatchDirectorSell2,500$97.44$243,600.002,500View SEC Filing  
8/18/2017Matt ScribnerEVPSell2,500$92.45$231,125.006,964View SEC Filing  
8/15/2017Raymond HuggenbergerDirectorSell14,000$91.67$1,283,380.007,808View SEC Filing  
8/10/2017Alison BauerleinEVPSell6,667$92.64$617,630.8815,000View SEC Filing  
7/18/2017Matt ScribnerEVPSell2,500$94.21$235,525.004,833View SEC Filing  
7/14/2017Raymond HuggenbergerDirectorSell14,000$92.96$1,301,440.007,808View SEC Filing  
6/16/2017Matt ScribnerEVPSell2,500$91.54$228,850.004,833View SEC Filing  
6/15/2017Raymond HuggenbergerDirectorSell15,300$90.88$1,390,464.007,808View SEC Filing  
6/2/2017Byron MyersEVPSell10,000$90.00$900,000.0045,185View SEC Filing  
6/1/2017Scott WilkinsonInsiderSell23,437$88.06$2,063,862.2254,088View SEC Filing  
5/30/2017Heath LukatchDirectorSell9,000$88.52$796,680.007,246View SEC Filing  
5/18/2017Ray Benjamin M AndersonDirectorSell4,445$81.05$360,267.254,445View SEC Filing  
5/10/2017Alison BauerleinEVPSell6,666$83.24$554,877.8425,758View SEC Filing  
4/24/2017Byron MyersEVPSell10,000$80.00$800,000.0045,185View SEC Filing  
4/17/2017Matt ScribnerEVPSell2,500$75.28$188,200.004,064View SEC Filing  
3/15/2017Matt ScribnerEVPSell2,500$73.85$184,625.004,833View SEC Filing  
2/28/2017Brenton TaylorEVPSell3,750$70.07$262,762.5031,851View SEC Filing  
1/17/2017Matt ScribnerEVPSell2,500$63.91$159,775.004,833View SEC Filing  
1/17/2017Raymond HuggenbergerCEOSell5,680$63.96$363,292.8012,488View SEC Filing  
1/10/2017Brenton TaylorEVPSell5,105$65.31$333,407.5531,851View SEC Filing  
1/3/2017Brenton TaylorEVPSell31,823$65.69$2,090,452.8763,674View SEC Filing  
12/15/2016Raymond HuggenbergerCEOSell8,000$65.59$524,720.0014,808View SEC Filing  
12/14/2016Matt ScribnerEVPSell2,500$65.13$162,825.004,833View SEC Filing  
12/1/2016Scott WilkinsonInsiderSell26,706$61.64$1,646,157.8466,050View SEC Filing  
11/14/2016Matt ScribnerEVPSell2,500$63.80$159,500.004,833View SEC Filing  
10/17/2016Raymond HuggenbergerCEOSell7,089$56.24$398,685.368,342View SEC Filing  
10/12/2016Matt ScribnerEVPSell4,551$59.45$270,556.956,884View SEC Filing  
9/19/2016Matt ScribnerEVPSell4,551$60.18$273,879.186,884View SEC Filing  
9/16/2016Byron MyersVPSell6,200$60.04$372,248.0041,385View SEC Filing  
9/9/2016Byron MyersVPSell3,800$60.07$228,266.0035,585View SEC Filing  
8/18/2016Matt ScribnerEVPSell2,320$56.39$130,824.804,653View SEC Filing  
8/15/2016Raymond HuggenbergerCEOSell20,747$57.48$1,192,537.5627,555View SEC Filing  
8/9/2016Byron MyersVPSell13,000$55.00$715,000.0035,185View SEC Filing  
7/18/2016Matt ScribnerEVPSell4,102$50.46$206,986.926,435View SEC Filing  
7/18/2016Raymond HuggenbergerCEOSell20,747$50.41$1,045,856.2727,555View SEC Filing  
6/16/2016Matt ScribnerEVPSell4,102$47.66$195,501.322,738View SEC Filing  
6/16/2016Raymond HuggenbergerCEOSell20,747$47.86$992,951.4227,555View SEC Filing  
5/16/2016Matt ScribnerEVPSell4,102$43.82$179,749.646,435View SEC Filing  
5/16/2016Raymond HuggenbergerCEOSell20,746$44.18$916,558.2827,554View SEC Filing  
4/15/2016Matt ScribnerEVPSell4,102$48.62$199,439.246,435View SEC Filing  
4/15/2016Raymond HuggenbergerCEOSell29,635$48.59$1,439,964.6525,210View SEC Filing  
4/13/2016Brenton TaylorEVPSell6,500$48.00$312,000.0031,851View SEC Filing  
4/6/2016Alison BauerleinCFOSell9,278$46.18$428,458.0438,332View SEC Filing  
3/31/2016Alison BauerleinCFOSell4,360$44.33$193,278.8048,332View SEC Filing  
2/16/2016Matt ScribnerEVPSell4,102$30.26$124,126.522,333View SEC Filing  
1/14/2016Matt ScribnerEVPSell4,102$34.73$142,462.462,333View SEC Filing  
12/14/2015Matt ScribnerEVPSell4,102$40.40$165,720.802,333View SEC Filing  
11/12/2015Matt ScribnerEVPSell4,102$44.52$182,621.042,333View SEC Filing  
10/26/2015Brenton TaylorEVPSell5,000$41.38$206,900.0043,351View SEC Filing  
10/21/2015Raymond HuggenbergerCEOSell57,418$43.06$2,472,419.086,808View SEC Filing  
10/12/2015Matt ScribnerEVPSell4,102$44.06$180,734.122,333View SEC Filing  
10/1/2015Alison BauerleinCFOSell10,185$47.94$488,268.9043,890View SEC Filing  
9/25/2015Brenton TaylorEVPSell3,333$53.48$178,248.8443,351View SEC Filing  
9/16/2015Byron MyersVPSell1,700$55.00$93,500.0036,332View SEC Filing  
9/15/2015Raymond HuggenbergerCEOSell57,416$53.58$3,076,349.286,808View SEC Filing  
9/14/2015Byron MyersVPSell7,950$55.23$439,078.5036,332View SEC Filing  
9/10/2015Matt ScribnerEVPSell4,102$53.30$218,636.604,666View SEC Filing  
9/1/2015Alison BauerleinCFOSell6,500$48.21$313,365.0049,075View SEC Filing  
8/26/2015Scott WilkinsonEVPSell6,666$45.42$302,769.72View SEC Filing  
8/25/2015Brenton TaylorEVPSell3,333$46.84$156,117.7246,684View SEC Filing  
8/25/2015Ray Benjamin M. AndersonDirectorSell5,658$46.36$262,304.884,896View SEC Filing  
5/28/2015Timothy PetersenDirectorSell337,081$37.44$12,620,312.64View SEC Filing  
5/26/2015Timothy PetersenDirectorSell54,258$37.05$2,010,258.90View SEC Filing  
5/22/2015Timothy PetersenDirectorSell86,889$37.09$3,222,713.01View SEC Filing  
5/21/2015Timothy PetersenDirectorSell134,300$37.81$5,077,883.00View SEC Filing  
5/19/2015Timothy PetersenDirectorSell115,700$37.25$4,309,825.00View SEC Filing  
5/18/2015Timothy PetersenDirectorSell58,987$37.35$2,203,164.45View SEC Filing  
3/5/2015Matt ScribnerEVPSell4,102$33.69$138,196.38View SEC Filing  
2/25/2015Brenton TaylorEVPSell15,687$33.87$531,318.69View SEC Filing  
2/23/2015Alison BauerleinCFOSell15,687$33.10$519,239.70View SEC Filing  
2/19/2015Raymond HuggenbergerCEOSell25,722$33.95$873,261.90View SEC Filing  
2/13/2015Scott WilkinsonEVPSell18,333$32.87$602,605.71View SEC Filing  
2/5/2015Matt ScribnerEVPSell4,102$30.66$125,767.32View SEC Filing  
2/3/2015Timothy PetersenDirectorSell17,000$30.25$514,250.00View SEC Filing  
2/2/2015Timothy PetersenDirectorSell99,000$30.88$3,057,120.00View SEC Filing  
1/29/2015Timothy PetersenDirectorSell601,000$31.95$19,201,950.00View SEC Filing  
1/26/2015Brenton TaylorEVPSell15,687$31.53$494,611.11View SEC Filing  
1/23/2015Alison BauerleinCFOSell15,687$31.53$494,611.11View SEC Filing  
1/20/2015Raymond HuggenbergerCEOSell25,722$31.63$813,586.86View SEC Filing  
1/5/2015Matt ScribnerEVPSell4,102$31.14$127,736.28View SEC Filing  
1/5/2015Versant Ventures Ii LlcMajor ShareholderSell7,946$30.98$246,167.08View SEC Filing  
12/30/2014Scott WilkinsonEVPSell962$30.50$29,341.00View SEC Filing  
12/29/2014Scott WilkinsonEVPSell15,735$30.52$480,232.20View SEC Filing  
12/24/2014Byron MyersVPSell7,514$30.07$225,945.98View SEC Filing  
12/23/2014Alison BauerleinCFOSell15,687$29.85$468,256.95View SEC Filing  
12/23/2014Byron MyersVPSell3,018$30.04$90,660.72View SEC Filing  
12/23/2014Versant Ventures Ii LlcMajor ShareholderSell9,785$29.74$291,005.90View SEC Filing  
12/22/2014Byron MyersVPSell11,801$30.06$354,738.06View SEC Filing  
12/22/2014Scott WilkinsonEVPSell1,033$30.31$31,310.23View SEC Filing  
12/19/2014Raymond HuggenbergerCEOSell25,722$28.98$745,423.56View SEC Filing  
12/11/2014Scott WilkinsonEVPSell14,700$25.25$371,175.00View SEC Filing  
12/3/2014Matt ScribnerEVPSell4,102$24.09$98,817.18View SEC Filing  
11/25/2014Brenton TaylorEVPSell15,687$24.71$387,625.77View SEC Filing  
11/21/2014Alison BauerleinCFOSell15,687$24.49$384,174.63View SEC Filing  
11/19/2014Raymond HuggenbergerCEOSell25,722$24.25$623,758.50View SEC Filing  
11/19/2014Versant Ventures Ii LlcMajor ShareholderSell28,225$24.77$699,133.25View SEC Filing  
11/18/2014Scott WilkinsonEVPSell2,233$25.21$56,293.93View SEC Filing  
11/18/2014Versant Ventures Ii LlcMajor ShareholderSell11,848$24.83$294,185.84View SEC Filing  
11/17/2014Versant Ventures Ii LlcMajor ShareholderSell5,343$24.89$132,987.27View SEC Filing  
11/14/2014Heather D RiderDirectorBuy3,000$25.00$75,000.00View SEC Filing  
11/14/2014Scott WilkinsonEVPSell1,100$25.15$27,665.00View SEC Filing  
11/14/2014Versant Ventures Ii LlcMajor ShareholderSell9,433$25.13$237,051.29View SEC Filing  
11/10/2014Versant Ventures Ii LlcMajor ShareholderSell2,992$24.42$73,064.64View SEC Filing  
11/7/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$24.30$179,528.40View SEC Filing  
11/4/2014A/S NovoMajor ShareholderSell2,000,000$21.50$43,000,000.00View SEC Filing  
11/4/2014Raymond HuggenbergerCEOSell165,891$20.21$3,352,657.11View SEC Filing  
11/4/2014Timothy PetersenDirectorSell250,000$21.50$5,375,000.00View SEC Filing  
11/3/2014Matt ScribnerEVPSell4,102$24.08$98,776.16View SEC Filing  
10/29/2014Scott WilkinsonEVPSell18,333$22.41$410,842.53View SEC Filing  
10/27/2014Brenton TaylorEVPSell15,687$21.67$339,937.29View SEC Filing  
10/24/2014Versant Ventures Ii LlcMajor ShareholderSell4,647$20.76$96,471.72View SEC Filing  
10/23/2014Alison BauerleinCFOSell15,687$20.50$321,583.50View SEC Filing  
10/9/2014Versant Ventures Ii LlcMajor ShareholderSell1,900$20.83$39,577.00View SEC Filing  
10/8/2014Versant Ventures Ii LlcMajor ShareholderSell6,907$21.03$145,254.21View SEC Filing  
10/7/2014Timothy PetersenDirectorSell31,600$21.55$680,980.00View SEC Filing  
10/6/2014Timothy PetersenDirectorSell17,475$21.56$376,761.00View SEC Filing  
10/3/2014Timothy PetersenDirectorSell31,658$21.52$681,280.16View SEC Filing  
10/3/2014Ventures Lp Arboretum IIMajor ShareholderSell98,400$20.97$2,063,448.00View SEC Filing  
10/2/2014Timothy PetersenDirectorSell24,597$20.91$514,323.27View SEC Filing  
10/1/2014Matt ScribnerEVPSell8,204$20.25$166,131.00View SEC Filing  
10/1/2014Timothy PetersenDirectorSell42,145$20.61$868,608.45View SEC Filing  
9/30/2014Timothy PetersenDirectorSell84,500$20.23$1,709,435.00View SEC Filing  
9/24/2014Ventures Lp Arboretum IIMajor ShareholderSell83,500$20.34$1,698,390.00View SEC Filing  
9/23/2014Alison BauerleinCFOSell15,687$20.01$313,896.87View SEC Filing  
9/22/2014Raymond HuggenbergerCEOSell25,722$20.25$520,870.50View SEC Filing  
9/22/2014Timothy PetersenDirectorSell46,865$21.05$986,508.25View SEC Filing  
9/17/2014Timothy PetersenDirectorSell39,135$21.72$850,012.20View SEC Filing  
9/17/2014Ventures Lp Arboretum IIMajor ShareholderSell55,135$21.61$1,191,467.35View SEC Filing  
9/16/2014Timothy PetersenDirectorSell6,500$21.16$137,540.00View SEC Filing  
9/15/2014Byron MyersVPSell22,333$21.33$476,362.89View SEC Filing  
9/15/2014Scott WilkinsonEVPSell18,333$21.42$392,692.86View SEC Filing  
9/15/2014Timothy PetersenDirectorSell9,500$21.45$203,775.00View SEC Filing  
9/9/2014Versant Ventures Ii LlcMajor ShareholderSell7,388$23.25$171,771.00View SEC Filing  
3/7/2014Charles E LarsenDirectorSell26,201$14.88$389,870.88View SEC Filing  
2/20/2014A/S NovoInsiderSell617,000$14.88$9,180,960.00View SEC Filing  
2/20/2014Loren L McfarlandDirectorBuy3,125$16.00$50,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Inogen (NASDAQ INGN) News Headlines

Source:
DateHeadline
Critical Survey: Inogen (INGN) versus VWR (VWR)Critical Survey: Inogen (INGN) versus VWR (VWR)
www.americanbankingnews.com - January 13 at 3:06 PM
Inogen (INGN) Lifted to Buy at Zacks Investment ResearchInogen (INGN) Lifted to Buy at Zacks Investment Research
www.americanbankingnews.com - January 9 at 3:56 PM
Inogen (INGN) vs. Neurometrix (NURO) Financial ComparisonInogen (INGN) vs. Neurometrix (NURO) Financial Comparison
www.americanbankingnews.com - January 6 at 9:12 PM
BidaskClub Downgrades Inogen (INGN) to SellBidaskClub Downgrades Inogen (INGN) to Sell
www.americanbankingnews.com - January 6 at 6:40 PM
 Analysts Expect Inogen Inc (INGN) Will Announce Quarterly Sales of $61.99 Million Analysts Expect Inogen Inc (INGN) Will Announce Quarterly Sales of $61.99 Million
www.americanbankingnews.com - January 6 at 6:32 AM
Inogen Inc (INGN) Director Ray Benjamin M. Anderson Sells 1,000 SharesInogen Inc (INGN) Director Ray Benjamin M. Anderson Sells 1,000 Shares
www.americanbankingnews.com - January 3 at 9:54 PM
Inogen Inc (INGN) Receives Consensus Recommendation of "Buy" from AnalystsInogen Inc (INGN) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 2 at 8:28 AM
ETFs with exposure to Inogen, Inc. : December 28, 2017ETFs with exposure to Inogen, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 3:07 PM
Inogen, Inc. :INGN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017Inogen, Inc. :INGN-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 27 at 1:27 PM
Inogen (INGN) Rating Lowered to Hold at BidaskClubInogen (INGN) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - December 25 at 4:27 PM
$61.99 Million in Sales Expected for Inogen Inc (INGN) This Quarter$61.99 Million in Sales Expected for Inogen Inc (INGN) This Quarter
www.americanbankingnews.com - December 20 at 6:32 AM
Inogen, Inc (INGN) Director Sells $1,678,880.00 in StockInogen, Inc (INGN) Director Sells $1,678,880.00 in Stock
www.americanbankingnews.com - December 19 at 8:50 PM
Inogen, Inc (INGN) EVP Matt Scribner Sells 2,500 SharesInogen, Inc (INGN) EVP Matt Scribner Sells 2,500 Shares
www.americanbankingnews.com - December 15 at 9:22 PM
Byron Myers Sells 10,000 Shares of Inogen, Inc (INGN) StockByron Myers Sells 10,000 Shares of Inogen, Inc (INGN) Stock
www.americanbankingnews.com - December 12 at 8:42 PM
Reviewing Palomar Medical Technologies (PMTI) & Inogen (INGN)Reviewing Palomar Medical Technologies (PMTI) & Inogen (INGN)
www.americanbankingnews.com - December 12 at 3:30 PM
Inogen, Inc (INGN) Receives Average Recommendation of "Buy" from AnalystsInogen, Inc (INGN) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - December 8 at 8:22 AM
Strange: Bullish INGN Analysts Actually See -9.56% Downside - NasdaqStrange: Bullish INGN Analysts Actually See -9.56% Downside - Nasdaq
www.nasdaq.com - December 7 at 10:45 AM
Inogen, Inc (INGN) Director Heath Lukatch Sells 2,500 SharesInogen, Inc (INGN) Director Heath Lukatch Sells 2,500 Shares
www.americanbankingnews.com - December 5 at 9:00 PM
Inogen, Inc (INGN) Expected to Announce Quarterly Sales of $61.99 MillionInogen, Inc (INGN) Expected to Announce Quarterly Sales of $61.99 Million
www.americanbankingnews.com - December 2 at 8:52 AM
 Brokerages Anticipate Inogen, Inc (INGN) Will Post Earnings of $0.21 Per Share Brokerages Anticipate Inogen, Inc (INGN) Will Post Earnings of $0.21 Per Share
www.americanbankingnews.com - November 30 at 9:28 AM
Inogen Announces Participation in 29th Annual Piper Jaffray Healthcare ConferenceInogen Announces Participation in 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 27 at 5:22 PM
Inogen, Inc (INGN) EVP Sells $4,086,950.00 in StockInogen, Inc (INGN) EVP Sells $4,086,950.00 in Stock
www.americanbankingnews.com - November 21 at 4:18 PM
Inogens (INGN) CEO Scott Wilkinson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaInogen's (INGN) CEO Scott Wilkinson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 14 at 12:58 AM
Inogen, Inc (INGN) Receives Consensus Rating of "Buy" from AnalystsInogen, Inc (INGN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - November 13 at 8:14 AM
Inogen, Inc (INGN) Expected to Announce Quarterly Sales of $61.97 MillionInogen, Inc (INGN) Expected to Announce Quarterly Sales of $61.97 Million
www.americanbankingnews.com - November 13 at 4:46 AM
Inogen (INGN) versus AtriCure (ATRC) Critical ReviewInogen (INGN) versus AtriCure (ATRC) Critical Review
www.americanbankingnews.com - November 13 at 3:34 AM
Inogen Claims Top Position in Deloitte List on Solid Growth - NasdaqInogen Claims Top Position in Deloitte List on Solid Growth - Nasdaq
www.nasdaq.com - November 11 at 12:27 PM
Inogen Claims Top Position in Deloitte List on Solid GrowthInogen Claims Top Position in Deloitte List on Solid Growth
finance.yahoo.com - November 11 at 12:27 PM
Analysts Offer Predictions for Inogen, Incs Q1 2018 Earnings (INGN)Analysts Offer Predictions for Inogen, Inc's Q1 2018 Earnings (INGN)
www.americanbankingnews.com - November 10 at 3:40 PM
FY2017 EPS Estimates for Inogen, Inc Decreased by William Blair (INGN)FY2017 EPS Estimates for Inogen, Inc Decreased by William Blair (INGN)
www.americanbankingnews.com - November 10 at 2:42 PM
William Blair Comments on Inogen, Incs Q3 2018 Earnings (INGN)William Blair Comments on Inogen, Inc's Q3 2018 Earnings (INGN)
www.americanbankingnews.com - November 9 at 1:48 PM
Inogen, Inc (INGN) Rating Increased to Buy at Zacks Investment ResearchInogen, Inc (INGN) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - November 9 at 1:00 PM
Q4 2017 Earnings Estimate for Inogen, Inc Issued By Leerink Swann (INGN)Q4 2017 Earnings Estimate for Inogen, Inc Issued By Leerink Swann (INGN)
www.americanbankingnews.com - November 9 at 9:58 AM
Inogen up 17% after Q3 beat - Seeking AlphaInogen up 17% after Q3 beat - Seeking Alpha
seekingalpha.com - November 9 at 6:50 AM
Inogen, Inc. breached its 50 day moving average in a Bullish Manner : INGN-US : November 8, 2017Inogen, Inc. breached its 50 day moving average in a Bullish Manner : INGN-US : November 8, 2017
finance.yahoo.com - November 9 at 6:50 AM
Inogen, Inc (INGN) Issues  Earnings Results, Beats Expectations By $0.04 EPSInogen, Inc (INGN) Issues Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - November 8 at 6:27 PM
Inogens (INGN) "Outperform" Rating Reiterated at Leerink SwannInogen's (INGN) "Outperform" Rating Reiterated at Leerink Swann
www.americanbankingnews.com - November 8 at 5:45 PM
McKesson (MCK) to Acquire RxCrossroads for $735 MillionMcKesson (MCK) to Acquire RxCrossroads for $735 Million
finance.yahoo.com - November 8 at 10:30 AM
Inogen Announces Record Third Quarter 2017 Financial ResultsInogen Announces Record Third Quarter 2017 Financial Results
finance.yahoo.com - November 8 at 10:29 AM
Inogen tops Street 3Q forecastsInogen tops Street 3Q forecasts
finance.yahoo.com - November 8 at 10:29 AM
Inogen (INGN) Beats Earnings and Revenue Estimates in Q3 - NasdaqInogen (INGN) Beats Earnings and Revenue Estimates in Q3 - Nasdaq
www.nasdaq.com - November 8 at 10:29 AM
Inogen Inc. (INGN) Has Leaped To A New High After Guidance Increase - NasdaqInogen Inc. (INGN) Has Leaped To A New High After Guidance Increase - Nasdaq
www.nasdaq.com - November 8 at 10:29 AM
Edited Transcript of INGN earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of INGN earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 8 at 10:29 AM
Inogen (INGN) Beats Earnings and Revenue Estimates in Q3Inogen (INGN) Beats Earnings and Revenue Estimates in Q3
finance.yahoo.com - November 8 at 10:29 AM
Top-Rated Stocks Near Buy Point With Earnings Due: InogenTop-Rated Stocks Near Buy Point With Earnings Due: Inogen
finance.yahoo.com - October 28 at 7:04 AM
Inogen, Inc. breached its 50 day moving average in a Bullish Manner : INGN-US : October 24, 2017Inogen, Inc. breached its 50 day moving average in a Bullish Manner : INGN-US : October 24, 2017
finance.yahoo.com - October 25 at 6:29 AM
$0.29 EPS Expected for Inogen Inc (INGN) This Quarter$0.29 EPS Expected for Inogen Inc (INGN) This Quarter
www.americanbankingnews.com - October 22 at 10:16 PM
ETFs with exposure to Inogen, Inc. : October 20, 2017ETFs with exposure to Inogen, Inc. : October 20, 2017
finance.yahoo.com - October 21 at 2:24 AM
Inogen to Announce Third Quarter 2017 Results on Tuesday, November 7, 2017Inogen to Announce Third Quarter 2017 Results on Tuesday, November 7, 2017
finance.yahoo.com - October 20 at 12:18 AM
Inogen, Inc (INGN) Given Consensus Rating of "Buy" by AnalystsInogen, Inc (INGN) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - October 19 at 6:46 AM

SEC Filings

Inogen (NASDAQ:INGN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Inogen (NASDAQ:INGN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Inogen (NASDAQ INGN) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.